These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34601988)

  • 1. Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document.
    Belinchón Romero I; Dauden E; Ferrándiz Foraster C; González-Cantero Á; Carrascosa Carrillo JM
    Ann Med; 2021 Dec; 53(1):1727-1736. PubMed ID: 34601988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of treatment goals for moderate to severe psoriasis: a European consensus.
    Mrowietz U; Kragballe K; Reich K; Spuls P; Griffiths CE; Nast A; Franke J; Antoniou C; Arenberger P; Balieva F; Bylaite M; Correia O; Daudén E; Gisondi P; Iversen L; Kemény L; Lahfa M; Nijsten T; Rantanen T; Reich A; Rosenbach T; Segaert S; Smith C; Talme T; Volc-Platzer B; Yawalkar N
    Arch Dermatol Res; 2011 Jan; 303(1):1-10. PubMed ID: 20857129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
    Daudén E; Puig L; Ferrándiz C; Sánchez-Carazo JL; Hernanz-Hermosa JM;
    J Eur Acad Dermatol Venereol; 2016 Mar; 30 Suppl 2():1-18. PubMed ID: 26812550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment goals for moderate to severe psoriasis: an Australian consensus.
    Baker C; Mack A; Cooper A; Fischer G; Shumack S; Sidhu S; Soyer HP; Wu J; Chan J; Nash P; Rawlin M; Radulski B; Foley P
    Australas J Dermatol; 2013 May; 54(2):148-54. PubMed ID: 23330815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Adult patients.
    Foley P; Gebauer K; Sullivan J; McMeniman E; Shumack S; Ng J; James A; Rawlin M; Sidhu S; Tilakaratne D; Turner M; Radulski B; Nash P; Baker C
    Australas J Dermatol; 2023 Nov; 64(4):476-487. PubMed ID: 37501636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.
    Carretero G; Puig L; Carrascosa JM; Ferrándiz L; Ruiz-Villaverde R; de la Cueva P; Belinchon I; Vilarrasa E; Del Rio R; Sánchez-Carazo JL; López-Ferrer A; Peral F; Armesto S; Eiris N; Mitxelena J; Vilar-Alejo J; A Martin M; Soria C;
    J Dermatolog Treat; 2018 Jun; 29(4):334-346. PubMed ID: 29099667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals.
    Mrowietz U; Kragballe K; Reich K; Griffiths CE; Gu Y; Wang Y; Rozzo SJ
    Br J Dermatol; 2013 Feb; 168(2):374-80. PubMed ID: 22880843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management.
    Puig L; Choon SE; Gottlieb AB; Marrakchi S; Prinz JC; Romiti R; Tada Y; von Bredow D; Gooderham M
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):737-752. PubMed ID: 36606566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing treatment goals for successful long-term management of psoriasis.
    Mrowietz U
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():12-20. PubMed ID: 22356631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management goals of type 1 Gaucher disease in South Africa: An expert Delphi consensus document on good clinical practice.
    Louw VJ; Fraser I; Giraldo P
    PLoS One; 2023; 18(8):e0290401. PubMed ID: 37607165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals.
    Norlin JM; Nilsson K; Persson U; Schmitt-Egenolf M
    Br J Dermatol; 2020 Apr; 182(4):965-973. PubMed ID: 31325318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic Therapeutic Approach for Patients with Plaque Psoriasis: Korean Expert Consensus Using the Modified Delphi Method.
    Jo SJ; Baek YS; Kim TG; Jeong KH; Kim JE; Choi YS; Kim B; Lee ES; Choe YB;
    Ann Dermatol; 2023 Jun; 35(3):173-182. PubMed ID: 37290951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations.
    Gisondi P; Talamonti M; Chiricozzi A; Piaserico S; Amerio P; Balato A; Bardazzi F; Calzavara Pinton P; Campanati A; Cattaneo A; Dapavo P; De Simone C; Dini V; Fargnoli MC; Flori ML; Galluzzo M; Guarneri C; Lasagni C; Loconsole F; Lo Schiavo A; Malagoli P; Malara G; Mercuri SR; Musumeci ML; Naldi L; Papini M; Parodi A; Potenza C; Prignano F; Rongioletti F; Stingeni L; Tiberio R; Venturini M; Bianchi L; Costanzo A; Cusano F; Girolomoni G; Offidani AM; Peris K
    Dermatol Ther (Heidelb); 2021 Feb; 11(1):235-252. PubMed ID: 33426634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis.
    Robinson A; Kardos M; Kimball AB
    J Am Acad Dermatol; 2012 Mar; 66(3):369-75. PubMed ID: 22041254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method.
    Richard MA; Aubin F; Beneton N; Bouloc A; Bursztejn AC; Descamps V; Jullien D
    Adv Ther; 2022 Nov; 39(11):5203-5215. PubMed ID: 36112312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
    Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
    Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm.
    Poizeau F; Leducq S; Fardet L; Beylot-Barry M; Chaby G; Chastagner M; Corgibet F; Gouillon L; Jouan N; Jullien D; Acher A; Amatore F; Amici JM; Aubert H; Aubin F; Beneton N; Bouilly D; Bursztejn AC; Buzenet C; Chamaillard-Pujol M; Charles J; Cottencin-Charriere AC; Duval Modeste B; Fauconneau A; Fougerousse AC; Girard C; Goujon C; Khemis A; Le Ru Y; Lepelley-Dupont C; Mahé E; Marcellin X; Nicolas C; Pallure V; Parier J; Quiles N; Stoebner PE; Tauber M; Vermersch A; Viguier M; Villani AP; Chosidow O; Guillot B;
    Ann Dermatol Venereol; 2024 Jul; 151(3):103287. PubMed ID: 39013256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuation.
    Arcese A; Aste N; Bettacchi A; Camplone G; Cantoresi F; Caproni M; D'Amico D; Fabbri P; Filosa G; Galluccio A; Hansel K; Lisi P; Micali G; Musumeci ML; Nicolini M; Parodi A; Patania M; Pezza M; Potenza C; Richetta A; Simonacci M; Trevisan P; Valenti G; Calvieri S
    Clin Drug Investig; 2010; 30(8):507-16. PubMed ID: 20586516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.
    Fargnoli MC; Bardazzi F; Bianchi L; Dapavo P; Fabbrocini G; Gisondi P; Micali G; Offidani AM; Pellacani G; Skroza N; Angileri RG; Burlando M; Campanati A; Carrera CG; Chiricozzi A; Conti A; Simone C; Di Lernia V; Errichetti E; Galluzzo M; Guarneri C; Lasagni C; Lembo S; Loconsole F; Megna M; Musumeci ML; Prignano F; Richetta AG; Trovato E; Venturini M; Peris K; Pinton PC
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.